Simplex Trading’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $525K | Sell |
126,107
-25,724
| -17% | -$97.7K | ﹤0.01% | 3545 |
|
|
2026
Q1 | $533K | Sell |
151,831
-177,232
| -54% | -$567K | ﹤0.01% | 3177 |
|
|
2025
Q4 | $898K | Buy |
329,063
+46,903
| +17% | +$109K | ﹤0.01% | 2733 |
|
|
2025
Q3 | $612K | Sell |
282,160
-4,429
| -2% | -$10.5K | ﹤0.01% | 3579 |
|
|
2025
Q2 | $492K | Buy |
286,589
+244,025
| +573% | +$607K | ﹤0.01% | 3525 |
|
|
2025
Q1 | $141K | Sell |
42,564
-27,889
| -40% | -$144K | ﹤0.01% | 4692 |
|
|
2024
Q4 | $521K | Sell |
70,453
-85,119
| -55% | -$789K | ﹤0.01% | 3497 |
|
|
2024
Q3 | $1.46M | Buy |
155,572
+70,850
| +84% | +$671K | ﹤0.01% | 2556 |
|
|
2024
Q2 | $679K | Buy |
84,722
+51,527
| +155% | +$552K | ﹤0.01% | 3336 |
|
|
2024
Q1 | $491K | Sell |
33,195
-340,872
| -91% | -$3.97M | ﹤0.01% | 3883 |
|
|
2023
Q4 | $3.04M | Buy |
374,067
+198,650
| +113% | +$1.04M | ﹤0.01% | 1995 |
|
|
2023
Q3 | $798K | Buy |
175,417
+99,375
| +131% | +$649K | ﹤0.01% | 2898 |
|
|
2023
Q2 | $535K | Buy |
76,042
+52,466
| +223% | +$376K | ﹤0.01% | 3238 |
|
|
2023
Q1 | $144K | Buy |
+23,576
| New | +$163K | ﹤0.01% | 4729 |
|
|
2022
Q4 | – | Sell |
-345
| Closed | -$2.69K | – | 9745 |
|
|
2022
Q3 | $3K | Buy |
+345
| New | +$3.98K | ﹤0.01% | 9099 |
|
|
2022
Q2 | – | Sell |
-26,505
| Closed | -$347K | – | 10471 |
|
|
2022
Q1 | $441K | Sell |
26,505
-28,471
| -52% | -$440K | ﹤0.01% | 3994 |
|
|
2021
Q4 | $1.05M | Buy |
+54,976
| New | +$1.21M | ﹤0.01% | 2794 |
|
|
2021
Q2 | – | Sell |
-10,327
| Closed | -$268K | – | 10341 |
|
|
2021
Q1 | $0 | Buy |
+10,327
| New | +$428K | ﹤0.01% | 9357 |
|
|
2020
Q4 | – | Sell |
-12,359
| Closed | -$491K | – | 8673 |
|
|
2020
Q3 | $406K | Buy |
+12,359
| New | +$379K | ﹤0.01% | 3247 |
|
|
2020
Q2 | – | Sell |
-24,875
| Closed | -$818K | – | 7951 |
|
|
2020
Q1 | $744K | Buy |
24,875
+809
| +3% | +$21.4K | ﹤0.01% | 2173 |
|
|
2019
Q4 | $666K | Buy |
24,066
+10,323
| +75% | +$235K | ﹤0.01% | 2465 |
|
|
2019
Q3 | $250K | Sell |
13,743
-5,492
| -29% | -$121K | ﹤0.01% | 3337 |
|
|
2019
Q2 | $471K | Buy |
+19,235
| New | +$290K | ﹤0.01% | 2620 |
|
|
2019
Q1 | – | Sell |
-2,164
| Closed | -$21K | – | 7439 |
|
|
2018
Q4 | $19K | Buy |
2,164
+1,164
| +116% | +$11.2K | ﹤0.01% | 5368 |
|
|
2018
Q3 | $11K | Sell |
1,000
-15,429
| -94% | -$219K | ﹤0.01% | 6355 |
|
|
2018
Q2 | $210K | Sell |
16,429
-29,690
| -64% | -$434K | ﹤0.01% | 3426 |
|
|
2018
Q1 | $779K | Buy |
+46,119
| New | +$698K | 0.03% | 496 |
|
|
2017
Q4 | – | Sell |
-1,784
| Closed | -$14.3K | – | 6298 |
|
|
2017
Q3 | $13K | Sell |
1,784
-3,541
| -66% | -$22.4K | ﹤0.01% | 3545 |
|
|
2017
Q2 | $39K | Sell |
5,325
-3,853
| -42% | -$24.5K | ﹤0.01% | 2619 |
|
|
2017
Q1 | $68K | Sell |
9,178
-10,385
| -53% | -$76.1K | ﹤0.01% | 2080 |
|
|
2016
Q4 | $135K | Buy |
19,563
+4,480
| +30% | +$30.8K | 0.01% | 1310 |
|
|
2016
Q3 | $124K | Sell |
15,083
-57,257
| -79% | -$484K | 0.01% | 1371 |
|
|
2016
Q2 | $585K | Buy |
+72,340
| New | +$454K | 0.04% | 465 |
|
|
2015
Q4 | – | Sell |
-6,809
| Closed | -$47.3K | – | 5720 |
|
|
2015
Q3 | $39K | Buy |
+6,809
| New | +$53K | ﹤0.01% | 2182 |
|
Other funds holding IOVA
MFM
PAI
Simplex Trading's IOVA Position: Q2 2026 in Review
Simplex Trading reduced its Iovance Biotherapeutics (IOVA) stake by 17% in Q2 2026, selling an estimated $97.7K and leaving 126,107 shares worth $525K. The position accounts for ﹤0.01% of the portfolio, ranked #3545.
Simplex Trading first reported a position in IOVA in Q3 2015 and has held it in 34 quarters since. The position peaked at $3.04M in Q4 2023. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.
- Simplex Trading held 126,107 shares of Iovance Biotherapeutics worth $525K as of Q2 2026.
- Simplex Trading sold 25,724 Iovance Biotherapeutics shares in Q2 2026, an estimated $97.7K.
- Iovance Biotherapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #3545 holding.
- Simplex Trading first reported a position in Iovance Biotherapeutics in Q3 2015 and has held it in 34 quarters since.
- Simplex Trading's Iovance Biotherapeutics position peaked at $3.04M in Q4 2023.
- 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.